Anti-nerve growth factor in pain management: current evidence

Anti-nerve growth factor in pain management: current evidence

David S Chang,1 Eugene Hsu,2 Daniel G Hottinger,1 Steven P Cohen1,3–5 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 2Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, CA, 3Departmen...

Full description

Bibliographic Details
Main Authors: Chang DS, Hsu E, Hottinger DG, Cohen SP
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:Journal of Pain Research
Subjects:
Nociceptive pain
Neuropathic pain
drug discovery
tanezumab
fasinumab
fulranumab
Online Access:https://www.dovepress.com/anti-nerve-growth-factor-in-pain-management-current-evidence-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/anti-nerve-growth-factor-in-pain-management-current-evidence-peer-reviewed-article-JPR

Similar Items